Similarly, our results from liver transcriptomics and qPCR suggested that ApoA5 deficiency coordinating with HFD promoted an activation of the inflammatory and fibrotic pathways, then leading to NASH (Figure 4O-4Q; Figure S2A and 2B). Here, APOA5 is linked to metabolic dysfunction-associated steatohepatitis.